HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line.

Abstract
The AML1-ETO fusion transcription factor generated by the t(8;21) translocation is considered to deregulate the expression of genes that are crucial for normal differentiation and proliferation of hematopoietic progenitors, resulting in acute myelogenous leukemia by recruiting co-repressor complexes to DNA. To investigate the role of AML1-ETO in leukemogenesis, we transfected the cloned AML1-ETO cDNA and expressed the AML1-ETO protein in U937 myelomonocytic leukemia cells. By focusing on the anti-apoptotic gene Bcl-2, the key regulator gene of granulocytic differentiation CCAAT/enhancer-binding protein α (CEBPA) and the tumor suppressor gene p14(ARF), we found that both AML1-ETO-expressing cell lines and t(8;21) leukemia samples displayed low levels of these three genes. Chromatin immunoprecipitation assays demonstrated that Bcl-2, CEBPA and p14(ARF) were direct transcriptional targets of AML1-ETO. The universal binding of AML1-ETO to genomic DNA resulted in recruitment of methyl-CpG binding protein 2 (MeCP2), reduction of histone H3 or H4 acetylation and increased trimethylation of histone H3 lysine 9 as well as lysine 27 indicating that AML1-ETO induced heterochromatic silencing of Bcl-2, CEBPA and p14(ARF). These results suggested that the aberrant transcription factor AML1-ETO epigenetically silenced the function of the Bcl-2, CEBPA and p14(ARF) genes by inducing repressed chromatin configurations at their promoters through histone modifications.
AuthorsWen-Yue Zhuang, Jian-Nong Cen, Yun Zhao, Zi-Xing Chen
JournalOncology reports (Oncol Rep) Vol. 30 Issue 1 Pg. 185-92 (Jul 2013) ISSN: 1791-2431 [Electronic] Greece
PMID23673926 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AML1-ETO fusion protein, human
  • CCAAT-Enhancer-Binding Proteins
  • CEBPA protein, human
  • Core Binding Factor Alpha 2 Subunit
  • DNA-Binding Proteins
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins c-bcl-2
  • RUNX1 Translocation Partner 1 Protein
  • Tumor Suppressor Protein p14ARF
Topics
  • CCAAT-Enhancer-Binding Proteins (genetics)
  • Cell Differentiation (genetics)
  • Cell Line, Tumor
  • Cell Proliferation
  • Chromatin Immunoprecipitation
  • Core Binding Factor Alpha 2 Subunit (metabolism)
  • DNA-Binding Proteins (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Leukemia, Myelomonocytic, Acute (genetics, metabolism)
  • Oncogene Proteins, Fusion (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (genetics)
  • RUNX1 Translocation Partner 1 Protein
  • Tumor Suppressor Protein p14ARF (genetics)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: